About e-Nicotine Technology
e-Nicotine Technology is a company based in Los Gatos (United States) founded in 2012. e-Nicotine Technology has raised $3.98 million across 2 funding rounds from investors including Life Science Angels and North Texas Angel Network. e-Nicotine Technology operates in a competitive market with competitors including Pivot, Chrono Therapeutics, Velectron labs, ODEN Health Solutions and Lana Exprience, among others.
- Headquarter Los Gatos, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.98 M (USD)
in 2 rounds
-
Latest Funding Round
$400 K (USD), Debt – Conventional
Oct 29, 2014
-
Investors
Life Science Angels
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of e-Nicotine Technology
e-Nicotine Technology has successfully raised a total of $3.98M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $400 thousand completed in October 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in e-Nicotine Technology
e-Nicotine Technology has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Life Science Angels and North Texas Angel Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life sciences startups are funded by a non-profit angel network.
|
Locked | Locked | Locked | |
|
Early-stage companies are supported through angel investment funding.
|
Locked | Locked | Locked |
Investor details for e-Nicotine Technology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by e-Nicotine Technology
Investment portfolio details for e-Nicotine Technology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - e-Nicotine Technology
Detailed financials for e-Nicotine Technology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
E-Nicotine Technology Comparisons
Peer comparison for e-Nicotine Technology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of e-Nicotine Technology
e-Nicotine Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pivot, Chrono Therapeutics, Velectron labs, ODEN Health Solutions and Lana Exprience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital health solutions for tobacco cessation are provided by Pivot.
|
|
| Locked | Locked | Locked |
Develops transdermal nicotine replacement therapy for smoking cessation.
|
|
| Locked | Locked | Locked |
Wearable anti-addiction devices are developed for customer support.
|
|
| Locked | Locked | Locked |
Delivers comprehensive drug overdose detection devices for addiction treatment programs.
|
|
| Locked | Locked | Locked |
Offers smart solutions for individuals dealing with substance use disorders.
|
Detailed competitors of e-Nicotine Technology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on E-Nicotine Technology
Complete news archive for e-Nicotine Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about e-Nicotine Technology
e-Nicotine Technology was founded in 2012 and raised its 1st funding round 1 year after it was founded.
e-Nicotine Technology is headquartered in Los Gatos, United States. It is registered at Los Gatos, California, United States.
e-Nicotine Technology is a funded company, having raised a total of $3.98M across 2 funding rounds to date.
e-Nicotine Technology (eNT) is a healthcare company to which has developed a device for nicotine delivery as a substitute of cigarettes. Produces a condensation aerosol of nicotine using a proprietary thermal drug delivery technology. The eNT platform produces the right dose of the right sized nicotine particles for deep lung delivery resulting in craving reduction. No carcinogens as found in cigarette smoke. The company claims that their product uses 40-70 less nicotine than conventional cigarettes or e-cigarettes.
e-Nicotine Technology's top competitors include Pivot, Velectron labs and Neurotype.
e-Nicotine Technology has 2 investors. Key investors include Life Science Angels, and North Texas Angel Network.